167 related articles for article (PubMed ID: 10510167)
21. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
Johansson PA; Andersson M; Andersson KE; Cenci MA
Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
[TBL] [Abstract][Full Text] [Related]
22. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
23. The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat.
Bhargava HN; Gulati A
NIDA Res Monogr; 1990; 105():530-1. PubMed ID: 1652091
[No Abstract] [Full Text] [Related]
24. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
[TBL] [Abstract][Full Text] [Related]
25. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
27. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
28. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
[TBL] [Abstract][Full Text] [Related]
29. Morphine attenuates the effects of juvenile isolation in rats.
Van den Berg CL; Van Ree JM; Spruijt BM
Neuropharmacology; 2000 Apr; 39(6):969-76. PubMed ID: 10727707
[TBL] [Abstract][Full Text] [Related]
30. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
Ulens C; Van Boven M; Daenens P; Tytgat J
J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
[TBL] [Abstract][Full Text] [Related]
31. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.
Mignat C; Wille U; Ziegler A
Life Sci; 1995; 56(10):793-9. PubMed ID: 7885194
[TBL] [Abstract][Full Text] [Related]
32. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography.
Tempel A; Zukin RS
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4308-12. PubMed ID: 3035579
[TBL] [Abstract][Full Text] [Related]
33. Similar anticonvulsant, but unique, behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil.
Lee RJ; Bajorek JG; Lomax P
Neuropharmacology; 1984 May; 23(5):517-24. PubMed ID: 6330606
[TBL] [Abstract][Full Text] [Related]
34. The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats.
Liang J; Li Y; Ping X; Yu P; Zuo Y; Wu L; Han JS; Cui C
Peptides; 2006 Dec; 27(12):3307-14. PubMed ID: 17097192
[TBL] [Abstract][Full Text] [Related]
35. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
Picker MJ; Negus SS; Powell KR
Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
[TBL] [Abstract][Full Text] [Related]
36. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
[TBL] [Abstract][Full Text] [Related]
37. Cortical and striatal mu-opioid receptors are altered by gonadal hormone treatment but not by prenatal morphine exposure in adult male and female rats.
Slamberová R; Rimanóczy A; Schindler CJ; Vathy I
Brain Res Bull; 2003 Nov; 62(1):47-53. PubMed ID: 14596891
[TBL] [Abstract][Full Text] [Related]
38. Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice.
Boutin H; Catherine A; Mackenzie ET; Jauzac P; Dauphin F
Acta Neuropathol; 2007 Nov; 114(5):491-500. PubMed ID: 17676326
[TBL] [Abstract][Full Text] [Related]
39. Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy.
Stevens CW; Seybold VS
Brain Res; 1995 Jul; 687(1-2):53-62. PubMed ID: 7583313
[TBL] [Abstract][Full Text] [Related]
40. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study.
Brady LS; Herkenham M; Long JB; Rothman RB
Brain Res; 1989 Jan; 477(1-2):382-6. PubMed ID: 2539233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
